AMAG Pharmaceuticals: 2Q Earnings Snapshot

August 2, 2018

WALTHAM, Mass. (AP) _ AMAG Pharmaceuticals Inc. (AMAG) on Thursday reported a loss of $20.1 million in its second quarter.

On a per-share basis, the Waltham, Massachusetts-based company said it had a loss of 58 cents. Losses, adjusted to account for discontinued operations, were 75 cents per share.

The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 21 cents per share.

The specialty drugmaker posted revenue of $146.3 million in the period, which also fell short of Street forecasts. Six analysts surveyed by Zacks expected $157.1 million.

AMAG Pharmaceuticals shares have risen 75 percent since the beginning of the year. The stock has increased 19 percent in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AMAG at https://www.zacks.com/ap/AMAG